Professor of Empire Innovation, University at Buffalo (2019)
PHF Presidential Professorship, OUHSC (2018)
Idea Award with Special Focus, Peer Reviewed Cancer Research Program (CDMRP, DOD) (2016)
Idea Expansion Award, Breast Cancer Research Program (CDMRP, DOD) (2014)
Research Scholar Grants Award, American Cancer Society (2013)
Breast Cancer Seed Grant: Stephenson Cancer Center (2011)
Idea Award, Breast Cancer Research Program (CDMRP, DOD) (2008)
Research/Scholarship Support Award, SDSU (2007)
Research/Scholarship Support Award for New faculty, SDSU (2006)
Postdoctoral Fellowship Award, Breast Cancer Research Program (CDMRP, DOD) (2003)
Health Science Fellowship - Korean Health Science Foundation (1996)
Research Expertise:
Pharmaceutical Chemistry & Drug Delivery: Pharmaceutical Chemistry, Drug Delivery, Photodynamic Therapy, Photochemistry, PK/PD Modeling
Grants and Sponsored Research:
July 2022–June 2027 Singlet Oxygen-cleavable Prodrugs for Treating Non-Muscle Invasive Bladder Cancers National Cancer Institute/ NIH Role: Principal Investigator $2,104,600
September 2018–August 2021 Mechanistic Studies of gamma-Glutamyl Transpeptidase inhibition: a Novel Approach to Modulating Serum Levels of Cysteine NIGMS Role: Co-Investigator $975,672
August 2017–July 2020 Visible Light-Controlled Combination Strategy for Treating Nonmuscle Invasive Bladder Cancers DoD/CDMRP/PRCRP Role: Principal Investigator $392,000
March 2015–January 2020 NIR-activatable Prodrugs for Treating Peritoneally Metastasized Ovarian Cancers NIH/NIGMS Role: Principal Investigator $1,517,000
September 2014–September 2017 A Synergistic Combination Therapy of Photodynamic Therapy and Chemotherapy for Breast Cancer DoD/CDMRP/BCRP Role: Principal Investigator $554,826
July 2016–June 2017 Administrative Supplement for purchasing 300 MHz NMR system NIH/NIGMS Role: Principal Investigator $128,900
July 2013–June 2016 Fluorescence Cystoscopy-Photodynamic Therapy for Early Bladder Cancers American Cancer Society Role: Principal Investigator $527,460
September 2012–August 2013 Identifying the DRUG target in dormant cancer cells NIH/NCI Role: Co-Investigator $81,281
February 2009–September 2012 Targeted Delivery and Remote-Controlled Release of Chemotherapeutic Agents DoD/CDMRP/BCRP Role: Principal Investigator $503,664
Patents:
BODIPY derivatives and methods of synthesis and use thereof (2017)
Singlet oxygen-labile linkers and methods of production and use thereof (2016)